Pan-genotypic Hep-C drug added to Thai health system
NewsThe first pan-genotypic Hepatitis C drug, which can be prescribed without the requirement for expensive and limited testing to determine...
Read more about Pan-genotypic Hep-C drug added to Thai health system
-
Getting India’s struggling Hep-C services re-open during COVID-19
Interview NewsFor the estimated 6-12 million people living with Hepatitis C in India, access to treatment was already way below the...
Read more about Getting India’s struggling Hep-C services re-open during COVID-19
-
Russian government issues its first health-related compulsory license
NewsA new year signals a new approach to access to medicines in the Russian Federation. Remdesivir, a drug patented by...
Read more about Russian government issues its first health-related compulsory license
-
New data demonstrates the impact of patents in Ukraine
News Research2020 will be remembered for COVID-19. The scale of the pandemic highlights the urgent need to ensure equitable access to...
Read more about New data demonstrates the impact of patents in Ukraine
-
A Tribute: Dr. Mongkol Na Songkhla – Putting Health Before Trade
NewsWe join our partner in Thailand, and activists around the world, to pay tribute to Dr. Mongkol Na Songkhla, a...
Read more about A Tribute: Dr. Mongkol Na Songkhla – Putting Health Before Trade
-
Thailand submits patent opposition on TB drug for children
NewsJohnson & Johnson’s TB drug, bedaquiline (BDQ) can improve lives. The pediatric version is not substantially different to the adult...
Read more about Thailand submits patent opposition on TB drug for children
-
Vietnam’s route to optimal, affordable HIV treatment
NewsFollowing civil society advice, Vietnam’s Ministry of Health recommended TLD for HIV treatment. This was back in November 2019. Vietnam...
Read more about Vietnam’s route to optimal, affordable HIV treatment
-
OPINION: Breaking a ‘vicious cycle’ of overpaying for HIV drugs in Ukraine
News Opinion“In November 2020, Ukraine finally shifted from the overpriced branded version of darunavir (DRV) to the more affordable generic version of...
Read more about OPINION: Breaking a ‘vicious cycle’ of overpaying for HIV drugs in Ukraine
-
HIV activists are essential to the COVID-19 response
News OpinionThe legacy of HIV activism is approaching a 40-year history, one which is inextricably linked with the actions of pharmaceutical...
Read more about HIV activists are essential to the COVID-19 response
-
COVID-19 vaccine announcements: Our view
NewsFollowing on from the BioNTech and Pfizer vaccine announcement earlier this month, where we expressed cautious optimism, but also the...
